ClinicalTrials.gg
RecruitingNCT07203963Updated Nov 24, 2025

Additional Effects of Niel-asher Technique on Patients With Adhesive Capsulitis

An interventional study of Niel-Asher Technique + sleeper stretch and sleeper stretch + Conventional Treatment in Adhesive Capsulitis, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Bursitis by Riphah International University — 17 open to participants now, 17 under way, none of them phase 3. Bursitis · Riphah International University.

Planned enrollment
29th of 52
36 · median 38
Started
2025
with 7 others
No phase
52 of 52
17 open now
Primary completion
2026-09
later than 11 of 16 live
Registered
40th of 52
by date

Among the 52 studies in Bursitis by Riphah International University, this one is the 29th largest by planned enrollment, is one of 8 that started in 2025, is one of 52 with no phase, reaches primary completion later than 11 of the 16 other live ones, and was the 40th registered.

Bursitis

384 studies on the registry are indexed under Bursitis; 111 are open to participants now.

Browse Bursitis studies →

Open to participants now

17 of the 52 studies in Bursitis by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

11 more — sign in →

By country, each count listing its studies:

All 17 open studies →

Where they have run

Who these studies take

Of the 65 Bursitis studies recruiting now, 16 (25%) set no upper age limit and 42 (65%) stop at 75 or younger; none take children under 18; 8 take healthy volunteers.

This study: 40 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Bursitis by Riphah International University, or all of them as a file.
02

Study summary

The aim of this randomized controlled trial is to find the additional effects of Niel-Asher technique along with sleeper stretch and conventional physical therapy on pain, shoulder ranges of motion and functional disability in patients with Adhesive capsulitis

Read the detailed description

Frozen shoulder is a musculoskeletal disorder and it is a painful shoulder condition, it is also known as adhesive capsulitis. This condition is usually caused by progressive fibrosis and contracture of glenohumeral joint capsule and it cause pain and stiffness in glenohumeral joint. In patients with adhesive capsulitis there is significant reduction of both active and passive ROMs. Adhesive capsulitis is more common in females than in males with the age range from 40-60 years. Most affected ROM in patient with adhesive capsulitis is external rotation but internal rotation and other range of motions of shoulder are also affected. Frozen shoulder is prevalent in 2-3% of general population, with variations across countries and regions. There are three stages of adhesive capsulitis. Patient in early stages usually present with inflammation which progressively changes into fibrotic changes. Its diagnosis is usually made on the basis of history and physical examination.

Shoulder joint capsule has different segments and each segment has some effect on shoulder ROMs in all directions. Thickness of joint capsule is primary restraint that cause reduction in ROMs in frozen shoulder patient. Fibrosis of glenohumeral joint capsule often cause effusion of long head of bicep brachi. Risk factor for adhesive capsulitis includes female gender specifically age greater than 45 and diabetes, Dupuytren contracture, immobilization of the shoulder, complex regional pain syndrome. Individuals with higher BMI with hyperlipidemia are at higher risk for adhesive capsulitis. A study on subjects with chronic non traumatic shoulder pain (n=72) showed high prevalence of MTrPs in all subjects; highest prevalence being in infraspinatus (78%) followed by upper trapezius (58%), middle trapezius (43%), deltoid and teres minor.

Niel-Asher technique mainly based on the principle of body's natural healing mechanisms. It targets adherent structures to release fibrosis. It also stimulates specific neural pathways by activating mechanoreceptors and helps CNS to enhance pain reduction and functional improvement. This technique remodels the shoulder capsule by relieving soft tissue adhesions. It also decreases nociceptive sensitivity, improves circulation that leads to pain relief and restoration of range of motion of shoulder joint. This technique employed deep stroking massage and compression of trigger points in five steps on major muscles such as rotator cuff muscles/ teres minor, Infraspinatus and deltoid muscle.

Sleeper stretch technique isolates the soft tissue restraints in the posterior shoulder to correct mobility and flexibility deficit. Sleeper stretch targets infraspinatus and teres minor muscles and improve shoulder ROMs and internal rotation by decreasing stiffness of the posterior capsule and muscle tendon tension.

This study aims to find the additional effect of Niel-Asher technique along with sleeper stretch and conventional therapy (which include exercise therapy and ischemic compression to release trigger points )on minimizing pain, improving shoulder ranges of motion and functional activities in individuals affected by Adhesive capsulitis.

03

Conditions studied

  • Adhesive Capsulitis

Browse trials for

Keywords

  • Niel-Asher Technique (NAT)
  • Sleeper stretch
  • trigger points
04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 40-60 years
  • Both Genders: Male and Female
  • Patient falls under diagnostic criteria for adhesive capsulitis which is Painful and limited active and passive glenohumeral ROM in capsular pattern (external rotation> abduction> internal rotation)
  • Patient diagnosed with adhesive capsulitis by orthopedic or general physician
  • Patient with phase two and three of adhesive capsulitis based on duration of symptoms
  • Patients of adhesive capsulitis with presence of trigger points in rotator cuff muscles and deltoid muscle (trigger points present in at least 1 or 2 of these muscles) based on simon and travell's criteria of trigger points diagnosis.

Exclusion criteria

Exclusion Criteria:

  • Spinal Injuries and any other co- morbidity
  • Any surgery, infection, trauma, pregnancy, fracture and fall
  • Patient with intra articular steroidal therapy with in last 6 months
  • Patient unwilling to comply follow up schedule
  • Patient involvement in another intervention study
  • Patient with thyroid disorders and RA and Glenohumeral OA
  • History of previous surgery or manipulation under anesthesia of affected shoulder
  • Patient with duration of symptoms of less than three months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
36 participants (estimated)

Study arms

  • Other
    Niel-Asher Technique+ sleeper stretch+ Conventional PT

    Niel-Asher Technique

    Other: Niel-Asher Technique + sleeper stretch

  • Other
    sleeper stretch + Conventional Treatment

    Sleeper stretch+ Conventional

    Other: sleeper stretch + Conventional Treatment

Interventions

  • OtherNiel-Asher Technique + sleeper stretch

    Niel-Asher Technique, Manual Soft Tissue releaser, Neuro-muscular release technique for adhesive capsulitis ( This manual technique will be applied for 3 days a week for 4 weeks).Sleeper stretch will be applied passively by investigator, pressure of the stretch will be held for 30 seconds (repeated twice with 30 seconds break for 3 days a week) Conventional PT including 1: shoulder anteroposterior, posteroanterior and inferior glides ( 3 times a week for 4 week) 2: active and active assisted ROM exercises of shoulder joint (frequency: 1 set of 10 repetitions twice a day). 3: Shoulder Isometric exercises, Codman's exercises and pulley and finger ladder exercises (frequency: 1 set of 10 repetitions twice a day), 4: trigger points will be released by applying ischemic pressure (90 seconds) on trigger points found in rotator cuff muscles.

  • Othersleeper stretch + Conventional Treatment

    Sleeper stretch will be applied passively by investigator, pressure of the stretch will be held for 30 seconds (repeated twice with 30 seconds break for 3 days a week). Conventional PT including 1: shoulder anteroposterior, posteroanterior and inferior glides ( 3 times a week for 4 week) 2: active and active assisted ROM exercises of shoulder joint (frequency: 1 set of 10 repetitions twice a day). 3: Shoulder Isometric exercises, Codman's exercises and pulley and finger ladder exercises (frequency: 1 set of 10 repetitions twice a day) 4: ischemic compression (90seconds hold) on trigger points found in rotator cuff muscles

06

What researchers measure

Primary outcomes

  1. Visual Analogue scale VAS

    It is a pain rating scale. The findings suggested that 100-mm VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain. Patient will be asked to verbally report the pain score

    Time frame: 4 weeks

  2. Shoulder pain and disability Index (SPADI)

    The shoulder pain and disability index (SPADI) was developed to measure Current shoulder pain and disability, it is widely used valid and reliable tool. The SPADI contains 13 items that assess two domains, a 5-item subscale that measures pain and 8-item subscale that measures disability.

    Time frame: 4 weeks

  3. Goniometer

    A goniometer will be used to measure the range of motion (ROM) of the Shoulder joint. Goniometer is an instrument that measures the available range of motion at a joint

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Shafi International Hospital
    Islamabad, Punjab Province 46600, Pakistan
    Recruiting
    • KINZA ANWAR, MS-OMPT · Contactkinza.anwar@riphah.edu.pk · +92-3239735427
    • MARIA BARKAT, MS-OMPT* · Contact
    • MARIA BARKAT, MS-OMPT* · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Sep 2026, 10 months after the start.

Of 219 non-industry interventional studies with no phase under Bursitis, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 17. This study's planned 10 months is close to that.

Counting every sponsor, half of 219 studies reached it within 10 months; a quarter within 5 and three quarters within 17.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2025
First posted
Oct 2, 2025
StartActual
Oct 25, 2025
Primary completionEst.
Sep 15, 2026
CompletionEst.
Sep 20, 2026
Last update
Nov 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07203963
Responsible party
Sponsor
First posted
Oct 2, 2025
Start date
Oct 25, 2025
Primary completion
Sep 15, 2026 (estimated)
Completion
Sep 20, 2026 (estimated)
Last update
Nov 24, 2025

Study contacts

KINZA ANWAR, MS-OMPT
Contact
kinza.anwar@riphah.edu.pk
+92-3239735427
KINZA ANWAR, MS-OMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion